Table 3.
Lieberman et al. [13] | Agius et al. [7] | McGorry et al. (2010) | Cornblatt [33] | Carrion et al. [36] | |
---|---|---|---|---|---|
Stage 0 | Potential for gene therapy | Psychoeducation | |||
Stage 0a | Psychotherapy | Antidepressant | |||
Stage 0b |
Antipsychotics Antidepressant Psychotherapy |
Antipsychotics Antidepressant |
|||
Stage 0c |
Antipsychotics Antidepressant Psychotherapy |
||||
Stage 1 |
Atypical antipsychotics Stress reduction therapy |
Antipsychotics Antidepressant Cognitive therapy |
Family psychoeducation Substance abuse reduction |
Antipsychotics Psychotherapy |
|
Stage 1a |
Counseling and problem solving Exercise |
||||
Stage 1b |
CBT Cognitive intervention |
||||
Stage 2 | Antipsychotics |
Optimize medication Psychosocial interventionsa |
Family psychoeducation CBT Substance abuse reduction Atypical antipsychotics Antidepressant/mood stabilizers Work rehabilitation |
||
Stage 3 | Antipsychotics and potential experimental agents as adjunctive treatment |
Optimize medication: clozapine Psychosocial interventionsa Relapse prevention |
|||
Stage 3a |
Medical strategies Psychosocial intervention |
||||
Stage 3b | Relapse prevention | ||||
Stage 3c | |||||
Stage 4 | Clozapine |
CBT cognitive behavioral therapy.
aFamiliy interventions, Compliance therapy, Relapse intervention, Psychoeducation.